On Monday, Liu Yuejin who is vice commissioner of China’s National Narcotics Control Commission announced at a press conference that China will strengthen supervision of industrial cannabis, including the hot topic of Sino-US trade negotiations, “Fentanyl”, and China will ban all types of Fentanyl.
This statement is seen as a victory for US President Trump’s negotiations on trade between China and U.S.A. At the G20 summit in Argentina in December 2018, Trump and Chinese President Xi Jinping mentioned the issue of “Fentanyl”. Trump has always tough on Fentanyl issue. According to the report, in recent years, “Fentanyl” has replaced heroin in the United States as the largest drug, and most of the “Fentanyl” circulating in the US market has entered the United States through China’s mail delivery. “Fentanyl” is an opioid drug that is 50 to 100 times potent than morphine and 30 to 50 times more potent than heroin. Because fentanyl is cheaper than heroin and more effective than heroin on the black market in the United States, it has slowly replaced heroin as the most dangerous drug in the United States.
According to the US Centers for Disease Control and Prevention, one of the four people killed in the United States in 2018 used fentanyl. In 2018, 18,000 people died of fentanyl in 2018. US President Trump has repeatedly mentioned fentanyl’s affairs in the United States, and pointed the finger at China, and said that China is the real murderer behind the US “drug crisis”, saying that China let these drugs out. Liu Yuejin denied this statement at a press conference on Monday.
The Chinese start with fentanyl should have an important relationship with the Sino-US negotiations. However, some American experts believe that although the announcement has seen as good news, it still has reservations and doubts about China’s legal enforcement.